Low-Intensity Shockwave Lithotripsy (LISWT) for Erectile Dysfunction | Advanced Urology

What Is LISWT and How Does It Work?

Low-Intensity Shockwave Therapy (LISWT) is a non-invasive treatment that uses low-energy, focused acoustic waves to stimulate biological repair in erectile tissue. In vasculogenic erectile dysfunction (ED), the underlying issue is often impaired penile blood flow due to microvascular disease. LISWT targets this problem at its source: it promotes angiogenesis (new blood vessel formation), improves endothelial function, and supports smooth muscle and nerve recovery. Patients experience better rigidity, improved response to phosphodiesterase-5 inhibitors (like tadalafil), and more reliable erections over time.

At Advanced Urology, we use the Storz Duolith platform — the same device family that underpins many of the highest-quality LISWT research protocols. As referenced in our Advanced Recovery After Robotic Prostatectomy program, Duolith delivers focused energy consistently and precisely, which is crucial for reproducibility and depth of penetration. We do not use low-power radial devices marketed as “acoustic wave” systems, which are fundamentally different and not equivalent to focused LISWT.

Why Device Choice Matters: Focused vs. Radial “Acoustic Wave”

Focused LISWT (Duolith)

  • Delivers true shockwaves that converge at a defined focal point and depth.
  • Reproducible energy density across treatments, aligned with clinical research.
  • Penetrates target tissues associated with erectile function with precision.

Radial “Acoustic Wave” Devices

  • Emit pressure pulses that disperse superficially; not true focused shockwaves.
  • Inconsistent energy delivery and limited depth; outcomes are less predictable.
  • Often marketed to consumers, but not equivalent to focused LISWT protocols.

Bottom line: Clinical protocols and outcomes most often reference focused systems like Storz Duolith. This is the device we use for both primary ED therapy and for sexual recovery after prostate surgery.

Who Is a Good Candidate?

Often Good Candidates

  • Vasculogenic ED (cardiometabolic risk factors, early atherosclerosis).
  • Partial or inconsistent response to PDE5 inhibitors (tadalafil/sildenafil).
  • Penile hemodynamic deficits on evaluation (when available).
  • Post-prostatectomy ED (as part of a recovery plan — see below).

May Not Be Suitable

  • Severe neurogenic ED or extensive cavernous nerve injury.
  • Advanced Peyronie’s disease requiring additional therapies or surgery.
  • Uncontrolled cardiovascular disease; unstable medical status.

We begin with a targeted history and review of risk factors, medications, and prior ED treatments. When available, adjunctive testing (hormones, penile Doppler) helps personalize your plan. Our goal is to match the right therapy to the right patient and set realistic expectations.

The Advanced Urology LISWT Protocol

Core Treatment Plan

  • Device: Storz Duolith focused LISWT.
  • Frequency: 1 session per week.
  • Duration: 6 weeks total (standard initial course).
  • Technique: multi-site application along the penile shaft and crura.

Comfort: Sessions are well-tolerated, non-invasive, and require no anesthesia. You may resume normal activity immediately.

Adjuncts for Optimal Outcomes

  • Tadalafil 5 mg daily to enhance endothelial function and blood flow.
  • Lifestyle optimization: exercise, weight management, sleep, and cardiometabolic health.
  • Optional pelvic floor therapy if concomitant urinary symptoms or post-prostatectomy status.

What to Expect

  • Weeks 1–3: Early microvascular changes begin; some patients notice improved responsiveness.
  • Weeks 4–6: Ongoing endothelial repair and neovascularization; erections become more consistent.
  • Post-series: Improvements may continue to accrue for several weeks after the final session.

Note: Response varies by baseline severity, comorbidities, and adherence to adjunctive measures. Some patients benefit from a booster series months later.

Evidence and Outcomes

Multiple prospective studies and meta-analyses have shown meaningful improvements in validated ED scores (e.g., IIEF-EF) with focused LISWT, particularly in vasculogenic ED. Outcomes are strongest when patients adhere to complete protocols and combine therapy with cardiovascular risk optimization and PDE5 inhibitors. While individual results vary, clinical experience and published data support LISWT as a safe, non-invasive option that addresses the underlying microvascular component of ED.

Our choice of the Storz Duolith platform is intentional: it aligns with research-grade protocols and provides reproducible energy at depth. As noted in our Advanced Recovery After Robotic Prostatectomy program, Duolith is our gold-standard focused system for sexual recovery as well.

Safety and Side Effects

Typical Experience

  • Non-invasive treatments performed in the office.
  • No anesthesia or needles; minimal discomfort.
  • No activity restrictions after sessions.

Potential Effects

  • Transient redness or mild sensitivity at treatment sites.
  • Rare bruising; usually self-limited.
  • No systemic side effects typical of medications.

Comparing Options

TherapyHow It WorksProsConsiderations
LISWT (Duolith)Focused shockwaves promote angiogenesis and endothelial repair.Addresses root vascular issue; non-invasive; complements PDE5i.Series-based; best for vasculogenic ED; individual response varies.
PDE5 inhibitorsEnhance nitric oxide-mediated vasodilation.On-demand or daily use; widely available.Headache, flushing, interactions; do not repair microvasculature.
Injections (ICI)Direct cavernous smooth muscle relaxation.Highly effective; fast onset.Needle-based; training required; risk of priapism/fibrosis.
Implant (IPP)Surgical prosthesis provides reliable rigidity.Definitive solution when others fail.Surgery and recovery; device considerations.

After Prostate Surgery

Post-prostatectomy ED can reflect nerve recovery, microvascular injury, and smooth muscle changes. As outlined in our Advanced Recovery After Robotic Prostatectomy program, we combine daily tadalafil and focused LISWT (Duolith) to support endothelial health and tissue repair. Many patients also benefit from pelvic floor therapy to improve urinary control, which can positively impact sexual function and confidence.

Cost and Access

Pricing

Our LISWT program is typically offered as a 6-session series. Pricing is discussed during consultation; we offer transparent options and scheduling flexibility.

Next Steps

  • Consultation with an Advanced Urology provider to confirm candidacy.
  • Review of current medications and risk factors.
  • Personalized plan including LISWT, tadalafil, and lifestyle strategies.

Frequently Asked Questions

How long do results last?

Duration varies. Many patients enjoy sustained improvements for months; maintenance with risk-factor control and occasional boosters can help extend benefits.

Does it hurt?

Treatments are well-tolerated. Most patients describe a tapping sensation without significant pain. No anesthesia is required.

Can I combine LISWT with medications?

Yes. We often pair daily tadalafil 5 mg with LISWT to support endothelial function and responsiveness, unless contraindicated.

Is every “shockwave” device the same?

No. We use focused LISWT with the Storz Duolith. Radial “acoustic” devices are different and are not equivalent to focused LISWT in research protocols.